Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C459179 |
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide |
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [TGFB1 protein results in increased expression of TPSAB1 mRNA] | decreases reaction|increases expression | 16872693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TPSAB1 mRNA | affects expression | 16483693
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of TPSAB1 mRNA | increases expression | 15003993
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of TPSAB1 mRNA | affects cotreatment|increases expression | 17183730
|
C025299 |
polyphenols |
polyphenols results in decreased expression of TPSAB1 mRNA | decreases expression | 16293270
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of TPSAB1 mRNA | affects expression | 17450228
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of TPSAB1 mRNA | increases expression | 16054129
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of TPSAB1 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.82 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.17 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.90 | 18287403 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.08 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.28 | 17306315 16712894 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.81 | 15955085 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.61 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.76 | 17497229 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.21 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.31 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.40 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 18316065 18177632 17507914 20603192 17157402 18396377 18558336 19232924 18940202 19460635 16609825 17688650 15238991 18775368 18985861 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.68 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.18 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.85 | 16197459 16206674 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.54 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.25 | 16443354 16166294 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.93 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.54 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.18 | 16507464 17306315 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.18 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.88 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.88 | 16051514 16096774 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.22 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
3.14 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.93 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.78 | 20734317 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.54 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.75 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.01 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
2.70 | 16293270 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.74 | 9224671 14991402 9211117 9664655 9142499 16925845 9125849 17551590 10589399 8800419 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.74 | 8888407 17688650 16575769 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
4.41 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
4.41 | 1733752 19641884 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.31 | 1851702 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.84 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.25 | 16569247 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.46 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.29 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.04 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.80 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.60 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.40 | 3659116 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.75 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.54 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.26 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.41 | 18558336 8888407 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.82 | 17994277 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.02 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.15 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.34 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.54 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
3.01 | 9664655 14991402 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.36 | 12676792 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.20 | 17688650 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.40 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.88 | 16778211 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.93 | 16612254 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.14 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
polyphenols |
3.17 | 16366677 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.07 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.14 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.92 | 20008137 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.87 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.94 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
4.01 | 19850784 17596541 16294345 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
4.01 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.30 | 17217047 19642359 19225113 19035177 17506722 17339181 12679006 9834237 16935935 16331271 17649720 17368321 16788101 17712046 19075265 16766008 16823087 15748426 19029980 17107899 16891316 17294898 17361223 17301526 16140955 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.47 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
1.81 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
2.83 | 16698588 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
2.44 | 16712894 15276417 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.32 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.64 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
1.89 | 16712894 17306315 19931552 17077188 15276417 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.86 | 17453147 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.45 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.45 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.73 | 16940565 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.36 | 18803445 18765137 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.27 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.81 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.81 | 17596541 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.46 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.46 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.97 | 20056578 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.06 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
13.03 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
13.03 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
13.03 | 8888407 16359493 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
5.10 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
5.10 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.10 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.53 | 15976015 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.17 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.26 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.86 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.92 | 11422049 12752131 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.13 | 16723453 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
11.75 | 16283617 16116481 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
11.75 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.89 | 14763951 11044598 16876388 15475178 17978042 11738929 1511512 3137016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
10.10 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
10.10 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
10.10 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
10.16 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
10.16 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.92 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.63 | 17997062 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.21 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.02 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.61 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.36 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.86 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.58 | 17306315 16452187 16712894 11723127 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.95 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
10.18 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
10.18 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.99 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.76 | 17056641 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.34 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.18 | 16287080 |